GlassScriptPhysician profile
Christiane A Schaeffler
NPI 1073856464
$5,677.89
in general payments reported to CMS, 2019-2025
31 companies · $2,363 in 2025
The $2,363 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2022: $156 · 2023: $1,177 · 2024: $1,725 · 2025: $2,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,264.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,168.75 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $463.29 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $430.98 | 2022-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $334.86 | 2022-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.15 | 2023-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $213.59 | 2023-2025 | Evkeeza, Praluent |
| Janssen Pharmaceuticals, INC | $200.34 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $194.57 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $187.79 | 2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $137.36 | 2023-2025 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $129.08 | 2022-2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $122.16 | 2023-2024 | Opsumit, Uptravi |
| Novo Nordisk INC | $116.15 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $115.41 | 2019-2025 | Accolade Sr, Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.02 | 2023-2025 | Lifevest |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $68.70 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $59.69 | 2019-2024 | Wainua |
| Pfizer INC. | $48.17 | 2024-2025 | |
| Heartflow, INC. | $44.80 | 2022-2025 | |
| Irhythm Technologies, INC. | $37.64 | 2024 | Zio Xt Patch, Zio Monitor |
| Inspire Medical Systems, INC. | $32.50 | 2025 | Inspire |
| Bridgebio Pharma, INC. | $29.07 | 2025 | Attruby |
| Lilly USA, LLC | $24.52 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $22.37 | 2025 | |
| Kestra Medical Technology Services, INC. | $21.47 | 2025 | Assure Wcd |
| Recor Medical INC | $20.76 | 2024 | Paradise Renal Denervation System |
| Amarin Pharma, INC. | $19.83 | 2023 | |
| Idorsia Pharmaceuticals US INC | $17.87 | 2025 | Tryvio |
| Scpharmaceuticals INC. | $16.09 | 2024 | |
| Baxter Healthcare | $15.52 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christiane Schaeffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.